Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002778888 | SCV003587081 | uncertain significance | Inborn genetic diseases | 2021-12-03 | criteria provided, single submitter | clinical testing | The c.8819C>T (p.P2940L) alteration is located in exon 38 (coding exon 38) of the KMT2C gene. This alteration results from a C to T substitution at nucleotide position 8819, causing the proline (P) at amino acid position 2940 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003130876 | SCV003810113 | uncertain significance | Kleefstra syndrome 2 | 2021-06-22 | criteria provided, single submitter | clinical testing |